Skip to main content
Philogen logo

Philogen — Investor Relations & Filings

Ticker · PHIL ISIN · IT0005373789 LEI · 81560009EA1577917768 XMIL Manufacturing
Open in API
Filings indexed 377 across all filing types
Latest filing 2022-01-17 Director's Dealing
Country IT Italy
Listing XMIL PHIL

About Philogen

https://www.philogen.com

Philogen is a clinical-stage biotechnology company focused on the discovery and development of novel biopharmaceutical products for the treatment of cancer and other serious conditions associated with angiogenesis. Founded in 1996, the company's core strategy is based on innovating targeted therapies, such as antibody-cytokine fusions, which are designed to selectively deliver therapeutic agents to the site of disease. This approach aims to increase efficacy while reducing toxicity. Philogen operates as an integrated company with capabilities in research, GMP manufacturing, and clinical development of its proprietary product pipeline.

Recent filings

Filing Released Lang Actions
Comunicazione internal dealing
Director's Dealing Classification · 100% confidence The document is titled "Modello di notifica e di comunicazione al pubblico delle Operazioni Rilevanti da parte dei Soggetti Rilevanti Interni" (Notification and public communication model for Relevant Transactions by Inside Relevant Persons). It details a transaction (Acquisto di azioni sul mercato - Purchase of shares on the market) made by a director ('Consigliere') of Philogen S.p.A. on specific dates in January 2022. This type of filing, which reports personal share transactions by company directors and executives (insider trades), directly corresponds to the definition of Director's Dealing. This is not an Annual Report (10-K), Earnings Release (ER), or Interim Report (IR) as it focuses solely on insider trading disclosure, not comprehensive financial performance. It is a specific regulatory disclosure about insider transactions.
2022-01-17 Italian
AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE
Transaction in Own Shares Classification · 99% confidence The document is titled "AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE" (Update on the Share Buyback Program) and details the number of shares purchased by Philogen S.p.A. between January 10 and January 14, 2022, including daily transaction logs. This activity directly relates to the company buying back or selling its own shares. According to the definitions, this corresponds to the 'Transaction in Own Shares' category, coded as POS.
2022-01-17 Italian
Comunicazione internal dealing
Director's Dealing Classification · 100% confidence The document is a formal notification, written primarily in Italian, detailing a transaction made by a 'Soggetto Obbligato' (Reporting Person), Sergio Gianfranco Luigi Maria Dompé, who is a 'Consigliere' (Director) of Philogen S.p.A. Section 2(b) explicitly states the 'Natura dell'operazione' (Nature of the operation) as 'Acquisto di azioni sul mercato' (Purchase of shares on the market). Section 3 details the price and volume of the transaction, and Section 3(e) provides the date (January 2022). This structure perfectly matches the definition of insider trading disclosure, specifically reporting personal share transactions by directors and executives. This corresponds to the 'Director's Dealing' category. Filing Category: DIRS (Director's Dealing).
2022-01-13 Italian
AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE
Transaction in Own Shares Classification · 100% confidence The document is titled "AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE" (Update on the Share Buyback Program) and details the number of shares purchased by Philogen S.p.A. between January 3rd and January 7th, 2022, including daily transaction tables. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The code for this is POS.
2022-01-10 Italian
Allegato 3F
Director's Dealing Classification · 99% confidence The document is titled "SCHEMA DI COMUNICAZIONE DELLE OPERAZIONI SUI TITOLI DELL'EMITTENTE" (MODEL DISCLOSURE FOR TRANSACTIONS IN THE ISSUER'S SECURITIES). It details specific transactions (Type 'A' for Acquisition/Purchase) involving the issuer's shares (PHILOGEN S.p.A.) during December 2021. This structure and content directly correspond to regulatory filings reporting personal share transactions by company directors or executives (insider trades), even though the reporting party listed here is the Issuer itself, the format is characteristic of insider dealing disclosures. Reviewing the definitions: - 10-K/IR: Not a full annual or interim report. - ER/MRQ: Not an earnings release or major shareholding notification. - DIV/CAP/SHA: Not a dividend, financing, or general capital change announcement. - The content explicitly details 'OPERAZIONI SUI TITOLI' (Transactions in Securities) by an insider/related party, which aligns perfectly with the definition of Director's Dealing. Therefore, the appropriate classification is Director's Dealing (DIRS).
2022-01-07 Italian
AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE
Transaction in Own Shares Classification · 99% confidence The document is titled 'AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE' (Update on the Share Buyback Program) and details the number of own shares purchased by Philogen S.p.A. during a specific period (December 27 to December 30, 2021), including daily transaction breakdowns and total consideration. This activity directly relates to the company managing its own equity structure by repurchasing shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS). It is not a general earnings release (ER), an annual report (10-K), or a management discussion (MDA).
2022-01-03 Italian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.